newsfilter
← Latest News
PR Newswire·

BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...